Tamarly Intelligence
Form 13F · Avalo Therapeutics, Inc.

Who Holds Avalo Therapeutics, Inc. (AVTX)? 126 Institutional Holders, Q2 2026

Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 126 holders, $1.3 billion in total.

Largest holders

The 100 largest by value. Change in shares against Q1 2026.

ManagerSharesValueChange
FMR LLC5,100,216$94 million+77%13F
BlackRock, Inc.4,365,553$81 million+1235%13F
Deep Track Capital, LP3,610,000$67 millionNew13F
Caligan Partners LP3,163,866$58 million+94%13F
TCG Crossover Management, LLC3,017,120$56 million+309%13F
Affinity Asset Advisors, LLC2,900,000$54 million+116%13F
STATE STREET CORP2,889,287$53 million+3932%13F
FARALLON CAPITAL MANAGEMENT, L.L.C.2,498,000$46 million+173%13F
Point72 Asset Management, L.P.2,387,026$44 million+161%13F
Avoro Capital Advisors LLC2,333,333$43 million+65%13F
VANGUARD CAPITAL MANAGEMENT LLC2,264,246$42 million+215%13F
BVF INC/IL2,075,545$38 million+27%13F
BANK OF AMERICA CORP /DE/1,913,829$35 million+198%13F
Nantahala Capital Management, LLC1,862,250$34 million+51%13F
ADAGE CAPITAL PARTNERS GP, L.L.C.1,729,000$32 million+102%13F
Soleus Capital Management, L.P.1,654,978$31 million+274%13F
BRAIDWELL LP1,629,182$30 millionNew13F
ALLIANCEBERNSTEIN L.P.1,260,689$23 millionNew13F
UBS Group AG1,209,059$22 million+6%13F
Logos Global Management LP1,150,000$21 million+283%13F
GEODE CAPITAL MANAGEMENT, LLC1,105,118$20 million+550%13F
Commodore Capital LP1,018,319$19 million+111%13F
RA CAPITAL MANAGEMENT, L.P.1,000,000$18 million+51%13F
GOLDMAN SACHS GROUP INC946,320$17 million+1474%13F
Trails Edge Capital Partners, LP891,881$16 millionNew13F
AMERIPRISE FINANCIAL INC891,405$16 million+418%13F
Balyasny Asset Management L.P.861,711$16 million+18%13F
Vestal Point Capital, LP775,000$14 millionNew13F
Seven Fleet Capital Management LP770,765$14 million+260%13F
Parkman Healthcare Partners LLC766,290$14 millionNew13F
BOOTHBAY FUND MANAGEMENT, LLC702,051$13 million+117%13F
Squarepoint Ops LLC589,245$11 million+625%13F
BAKER BROS. ADVISORS LP550,000$10 millionNew13F
SILVERARC CAPITAL MANAGEMENT, LLC500,402$9 millionNew13F
Davern Capital Partners, LP468,666$9 millionNew13F
Pivotal bioVenture Partners Investment Advisor LLC434,033$8 million+47%13F
FRANKLIN RESOURCES INC404,191$7 millionNew13F
Boxer Capital Management, LLC375,000$7 million+25%13F
RENAISSANCE TECHNOLOGIES LLC357,200$7 million+197%13F
NORTHERN TRUST CORP344,521$6 million+1028%13F
DV EQUITIES, LLC332,213$6 millionNew13F
VANGUARD FIDUCIARY TRUST CO324,808$6 million+276%13F
Velan Capital Investment Management LP324,452$6 million+75%13F
CITADEL ADVISORS LLC323,833$6 million+67%13F
Schonfeld Strategic Advisors LLC310,008$6 millionNew13F
VANGUARD PORTFOLIO MANAGEMENT LLC284,702$5 millionNew13F
Vivo Capital, LLC275,000$5 millionNew13F
Eagle Health Investments LP235,093$4 millionNew13F
SPHERA FUNDS MANAGEMENT LTD.232,294$4 millionNew13F
PERCEPTIVE ADVISORS LLC219,813$4 million+57%13F
Caption Management, LLC210,000$4 million-54%13F
Jump Financial, LLC201,902$4 million+1476%13F
NAN FUNG TRINITY (HK) LTD189,000$3 million+0%13F
ACUTA CAPITAL PARTNERS, LLC186,308$3 million+206%13F
Walleye Capital LLC185,613$3 millionNew13F
RTW INVESTMENTS, LP175,000$3 million-80%13F
Ally Bridge Group (NY) LLC150,000$3 millionNew13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC137,475$3 million+1275%13F
BNP PARIBAS FINANCIAL MARKETS134,087$2 million-68%13F
CenterBook Partners LP132,869$2 millionNew13F
MORGAN STANLEY128,075$2 million-21%13F
Moody Aldrich Partners LLC125,582$2 million-21%13F
HighVista Strategies LLC122,610$2 million+109%13F
Aberdeen Group plc122,169$2 million-29%13F
SECTORAL ASSET MANAGEMENT INC119,923$2 millionNew13F
WELLINGTON MANAGEMENT GROUP LLP105,261$2 millionNew13F
Bank of New York Mellon Corp102,653$2 millionNew13F
Nuveen, LLC100,633$2 millionNew13F
Ikarian Capital, LLC90,183$2 millionNew13F
TD Asset Management Inc77,474$1 million+51%13F
CITIGROUP INC69,014$1 millionNew13F
TWO SIGMA INVESTMENTS, LP67,094$1 million+4%13F
Rafferty Asset Management, LLC56,411$1 millionNew13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE53,799$994,206New13F
RHUMBLINE ADVISERS53,290$984,789New13F
XTX Topco Ltd52,583$971,734-59%13F
DEUTSCHE BANK AG\41,166$760,747-73%13F
DIMENSIONAL FUND ADVISORS LP38,158$706,919-7%13F
Verition Fund Management LLC38,240$706,675New13F
Man Group plc36,876$681,468-21%13F
WELLS FARGO & COMPANY/MN36,576$675,924New13F
Verdad Advisers, LP32,827$606,643New13F
PROFUND ADVISORS LLC28,309$523,150New13F
GLENMEDE TRUST CO NA28,280$522,614+10%13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP27,227$503,155New13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.25,712$480,465New13F
Persistent Asset Partners Ltd24,544$453,573+210%13F
MetLife Investment Management, LLC24,499$452,742New13F
ENVESTNET ASSET MANAGEMENT INC22,539$416,521+13%13F
Invesco Ltd.22,226$410,736New13F
Virtus Investment Advisers, LLC22,168$409,665New13F
Vanguard Global Advisers, LLC20,010$369,785+257%13F
JPMORGAN CHASE & CO18,145$350,018-91%13F
SEI INVESTMENTS CO17,931$331,365-68%13F
BARCLAYS PLC17,811$329,147+22%13F
ExodusPoint Capital Management, LP16,495$304,828-7%13F
Quadrature Capital Ltd15,405$284,684-88%13F
NEW YORK STATE COMMON RETIREMENT FUND14,700$271,656New13F
Jain Global LLC12,686$234,437New13F
Woodline Partners LP12,544$231,813New13F

Questions and answers

How many institutions hold Avalo Therapeutics, Inc.?
126 managers reported Avalo Therapeutics, Inc. on Form 13F for the quarter ended 30 June 2026, against 97 the quarter before.
Who is the largest institutional holder of Avalo Therapeutics, Inc.?
FMR LLC, with 5,100,216 shares worth $94 million on its 13F for Q2 2026.
How many institutions bought or sold out of Avalo Therapeutics, Inc. in Q2 2026?
56 managers reported a new position and 27 reported none after holding it the quarter before.
See every holder, the full history and an alert when the next 13F filings land; the 7-day trial opens everything.Start the free trial

Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Avalo Therapeutics, Inc., Q2 2026", https://app.tamarly.ai/holders/avalo-therapeutics, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.

Who Holds Avalo Therapeutics, Inc. (AVTX)? 126 Institutional Holders, Q2 2026 | Tamarly